Recruiting Sjogrens Syndrome Studies in Denver
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome
The purpose of this study is to assess the safety and efficacy of two doses of Deucravacitinib in adult participants with Active Sjögren's Syndrome....
Nipocalimab in Moderate to Severe Sjogren's Disease
The purpose of this study is to evaluate the clinical efficacy and safety of nipocalimab in participants with moderate to severe Sjogren's disease (SjD)....
About Sjogrens Syndrome Clinical Trials in Denver
Sjogren's syndrome is a chronic autoimmune disorder in which the immune system attacks the glands that produce moisture, causing dry eyes and dry mouth. It can also affect joints, thyroid, kidneys, and other organs. Treatment focuses on relieving symptoms and may include immunosuppressive medications.
There are currently 2 sjogrens syndrome clinical trials recruiting participants in Denver, CO. These studies are seeking a combined 1,356 participants. Research is being sponsored by Bristol-Myers Squibb, Janssen Research & Development, LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
Sjogrens Syndrome Clinical Trials in Denver — FAQ
Are there sjogrens syndrome clinical trials in Denver?
Yes, there are 2 sjogrens syndrome clinical trials currently recruiting in Denver, CO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Denver?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Denver research site will contact you about next steps.
Are clinical trials in Denver free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Denver studies also compensate for your time and travel.
What sjogrens syndrome treatments are being tested?
The 2 active trials in Denver are testing new therapies including novel drugs, biologics, and treatment approaches for sjogrens syndrome.
Data updated March 2, 2026 from ClinicalTrials.gov